The Beneficial Effects of Alpha Lipoic Acid Supplementation on Lp-PLA2 Mass and Its Distribution between HDL and apoB-Containing Lipoproteins in Type 2 Diabetic Patients: A Randomized, Double-Blind, Placebo-Controlled Trial

The Beneficial Effects of Alpha Lipoic Acid Supplementation on Lp-PLA2 Mass and Its Distribution between HDL and apoB-Containing Lipoproteins in Type 2 Diabetic Patients: A Randomized, Double-Blind, Placebo-Controlled Trial

Lipoprotein-associated phospholipase A2 (Lp-PLA2) is a new specific vascular inflammation biomarker that is carried by the lipoproteins in the blood and plays a prominent role in the pathogenesis of atherosclerosis. Increased Lp-PLA2 levels and impaired Lp-PLA2 distribution across high-density lipop...

Full description

Bibliographic Details
Main Authors:	Nima Baziar, Ensieh Nasli-Esfahani, Kurosh Djafarian, Mostafa Qorbani, Mehdi Hedayati, Mahshid Abd Mishani, Zeinab Faghfoori, Najva Ahmaripour, Saeed Hosseini
Format:	Article
Language:	English
Published:	Hindawi Limited 2020-01-01
Series:	Oxidative Medicine and Cellular Longevity
Online Access:	http://dx.doi.org/10.1155/2020/5850865

Similar Items

The elevation of apoB in hypercholesterolemic patients is primarily attributed to the relative increase of apoB/Lp-PLA2
by: Constantinos C. Tellis, et al.
Published: (2013-12-01)

Interaction of LDL, Lp[a], and reduced Lp[a] with monoclonal antibodies against apoB.
by: A Gries, et al.
Published: (1988-01-01)

Structural basis of specific interactions of Lp-PLA2 with HDL revealed by hydrogen deuterium exchange mass spectrometry[S]
by: Jian Cao, et al.
Published: (2013-01-01)

Lp-PLA2 Inhibition—The Atherosclerosis Panacea?
by: Mahir Karakas, et al.
Published: (2010-04-01)

Effect of Pitavastatin Treatment on ApoB-48 and Lp-PLA in Patients with Metabolic Syndrome: Substudy of PROspective Comparative Clinical Study Evaluating the Efficacy and Safety of PITavastatin in Patients with Metabolic Syndrome
by: Hyo-Sun Lee, et al.
Published: (2016-03-01)

Further investigation of associations of Lp-PLA₂ with coronary heart disease
by: Gregson, John Michael
Published: (2014)

Unraveling the PAF-AH/Lp-PLA2 controversy1
by: Diana M. Stafforini, et al.
Published: (2014-09-01)

The interaction of human apoB-containing lipoproteins with mouse peritoneal macrophages: a comparison of Lp(a) with LDL.
by: F Krempler, et al.
Published: (1984-03-01)

Utility of non-HDL-C and apoB targets in the context of new more aggressive lipid guidelines
by: Renato Quispe, et al.
Published: (2021-09-01)

Influencing factors of serum Lp-PLA2 level in patients with diabetic retinopathy
by: Zhao-Hui Hui, et al.
Published: (2018-12-01)

Ability of Lp-PLA2 to correctly identify women with elevated carotid IMT
by: Rhodes, Philip G.
Published: (2011)

The ability of Lp-PLA2to correctly identify men with elevated carotid IMT
by: VanReenen, Jessica L.
Published: (2011)

Fenofibrate induces HDL-associated PAF-AH but attenuates enzyme activity associated with apoB-containing lipoproteins
by: Vasilis Tsimihodimos, et al.
Published: (2003-05-01)

Secretion from cell culture of HDL and VLDL bearing apoB-33 with a large internal deletion
by: M J Wu, et al.
Published: (1997-12-01)

Prehypertension-associated elevation in circulating lysophosphatidlycholines, Lp-PLA2 activity, and oxidative stress.
by: Minjoo Kim, et al.
Published: (2014-01-01)

Lipoprotein-associated phospholipase A2 (Lp-PLA2) in acute coronary syndrome
by: Jabor, Bashar
Published: (2016)

Identification of Inflammation-Related Biomarker Lp-PLA2 for Patients With COPD by Comprehensive Analysis
by: Mingming Deng, et al.
Published: (2021-05-01)

La muse : théâtre et théâtralité dans la photographie de mode
by: Esfahani, Najva
Published: (2013)

ApoA-I/A-II-HDL positively associates with apoB-lipoproteins as a potential atherogenic indicator
by: Toshimi Kido, et al.
Published: (2017-11-01)

The plasma concentration of HDL-associated apoM is influenced by LDL receptor-mediated clearance of apoB-containing particles
by: Christina Christoffersen, et al.
Published: (2012-10-01)

Evidence that Lp[a] contains one molecule of apo[a] and one molecule of apoB: evaluation of amino acid analysis data.
by: J J Albers, et al.
Published: (1996-01-01)

Genome-wide association study of Lp-PLA(2) activity and mass in the Framingham Heart Study.
by: Sunil Suchindran, et al.
Published: (2010-04-01)

Relationship between levels of Lp-PLA2 andpolymorphisms of I198T with coronary heart disease
by: Ling Zhang, et al.
Published: (2016-10-01)

Association of Lp-PLA2 Mass and Aysmptomatic Intracranial and Extracranial Arterial Stenosis in Hypertension Patients.
by: Yan Wang, et al.
Published: (2015-01-01)

Assessing associations of lipoprotein-associated phospholipase A₂ (Lp-PLA₂) with coronary heart disease risk
by: Thompson, Alexander John
Published: (2009)

Heterozygosity for apolipoprotein A-I(R160L)Oslo is associated with low levels of high density lipoprotein cholesterol and HDL-subclass LpA-I/A-II but normal levels of HDL-subclass LpA-I.
by: T P Leren, et al.
Published: (1997-01-01)

Healthy Dietary Pattern is Related to Blood Lipids in Patients with Type 1 Diabetes Mellitus: A Cross-sectional Study from a Developing Country
by: Zahra Sajjadpour, et al.
Published: (2021-01-01)

Application of Fetal Stem Cells in Diabetes: Iran’s Experience
by: Ali TOOTEE, et al.
Published: (2015-10-01)

Therapeutic Uses of Stem Cells in Endocrinology- Review Article
by: Ensieh NASLI ESFAHANI, et al.
Published: (2015-10-01)

The V279F polymorphism might change protein character and immunogenicity in Lp-PLA2 protein
by: Widodo, et al.
Published: (2018-04-01)

Diagnostic role and association of Lp-PLA2 with coronary artery disease in a South Indian population
by: S. Sai Giridhar, et al.
Published: (2017-11-01)

The relationship between Lp-PLA2 mass and activity and carotid intima media thickness (CIMT) in women
by: San Miguel, Michelle M.
Published: (2011)

A selective bi-site immunoenzymatic procedure for human Lp[a] lipoprotein quantification using monoclonal antibodies against apo[a] and apoB.
by: N Vu Dac, et al.
Published: (1989-09-01)

Association of carotid plaque Lp-PLA(2) with macrophages and Chlamydia pneumoniae infection among patients at risk for stroke.
by: Berna Atik, et al.
Published: (2010-06-01)

Impact of 8-week linoleic acid intake in soy oil on Lp-PLA2 activity in healthy adults
by: Minkyung Kim, et al.
Published: (2017-05-01)

Adenovirus-mediated gene transfer of Lp-PLA2 reduces LDL degradation and foam cell formation in vitro
by: Päivi Turunen, et al.
Published: (2004-09-01)

Comparison of apolipoprotein (apoB/apoA-I) and lipoprotein (total cholesterol/HDL) ratio determinants. Focus on obesity, diet and alcohol intake.
by: Gianluca Tognon, et al.
Published: (2012-01-01)

The effects of cranberry juice on serum glucose, apoB, apoA-I, Lp(a), and Paraoxonase-1 activity in type 2 diabetic male patients
by: Farzad Shidfar, et al.
Published: (2012-01-01)

Preprocedural Lp(a) level and ApoB/ApoA-Ι ratio and the risk for contrast-induced acute kidney injury in patients undergoing emergency PCI
by: Jun Tao, et al.
Published: (2021-10-01)

Quantitation of apoB-48 and apoB-100 by gel scanning or radio-iodination.
by: D B Zilversmit, et al.
Published: (1989-10-01)